May 31, 2023
Ambassador of Kyrgyz Republic H.E. Mr Ulanbek Totuiaev visits the manufacturing facility of Bio-Labs
It was an honor to host H.E Ambassador of Kyrgyz Republic, Mr Ulanbek Totuiaev during a visit to the manufacturing facility of Bio-Labs in Islamabad.
May 31, 2023
Ambassador of Kyrgyz Republic H.E. Mr Ulanbek Totuiaev visits the manufacturing facility of Bio-Labs
It was an honor to host H.E Ambassador of Kyrgyz Republic, Mr Ulanbek Totuiaev during a visit to the manufacturing facility of Bio-Labs in Islamabad.
May 23, 2023
Voriconazole (Voritic) is an antifungal drug. It is used to treat infections caused by some fungi.
January 10, 2023
Bio-Labs launched Zesert (Sertraline) in the Neuropsychiatry Division.
January 4, 2023
A MOU signing ceremony was held in local hotel in Islamabad between leading manufacturing pharmaceutical company Bio-Labs Pvt. Ltd.
November 7, 2022
We are proud to announce our recent launch of the Shopify website, our consumer health division products are just a click away.
August 19, 2022
Bio-Labs is proud to have received the “Best Pharmaceutical Entity 2022” award at the Rawalpindi Chamber of Commerce & Industry’s Annual Achievement Awards held in Bangkok on August 19, 2022 presented by the Thailand Deputy Prime Minister’s office. Our pursuit for excellence in pharmaceuticals shall continue with the same zeal and spirit going forward.
June 14, 2022
Bio-Labs (Pvt.) Ltd is proud and excited to sign the Memorandum of Understanding with N-ovative Health Technologies (NHT), an initiative of NUST, to bring its unique and advanced cardiac stents & catheters to the international markets.
June 7, 2022
In lieu of the severe drug shortages in Sri Lanka owing to the ongoing economic crisis, Bio-Labs was heart in hands to provide relief to the Sri Lankan brothers and sisters when reached out to by the Srilanka High commission Islamabad.
February 14, 2022
Bio-Labs added a new product to the psychiatry division, Qualey (Quetiapine Fumarate). Bio-Labs is pleased and honored to help people take a step “Towards the Peak of Stability” through this product.
February 8, 2022
After the landmark success of (Remdesivir),(Favipiravir) & (Molnupiravir) in our fight against covid-19, Bio-Labs once again proves its solid stance by the launch of FDA approved oral treatment to
effectively lower the Viral load of SARS-Cov-2 and other associated symptoms.
January 18, 2022
Mr. Khazar Farhadov during a delegation visit to the manufacturing facility of Bio-Labs in Islamabad.
January 8, 2022
Reliving the commitment and mission, Bio-Labs added a new product to its inventory. Bio-Labs is both gratified and proud to launch Merobio (Meropenem) recently with one and only aim that is VALUING LIFE.
December 15, 2021
Bio-Labs is proud to be the first pharmaceutical company in Pakistan
November 23, 2021
Bio-Labs is honored to receive the “Leading Pandemic Healthcare & Pharmaceutical Company Award”
November 23, 2021
Bio-Labs Signed Several MOUs with Leading Sri Lankan Pharmaceutical Entities for Joint Ventures
October 4, 2021
As the prevalence of Iron deficiency Anemia is on the all-time high, there is a need of a Rapid and safe way to replenish Serum Iron especially in pregnant females.
September 29, 2021
Islamabad: Bio-Labs has Received "The Leading Pharmaceutical Exporter Award"
September 28, 2021
August 14, 2021
A revolutionary development that controls symptoms of gastroesophageal reflux disease and cares for all digestive and stomach issues.
January 12, 2021
ZH Therapeutics is also the sole pharma company from Pakistan authorized to produce ZH Hand Sanitizer. It’s another great honor for everyone associated by ZH Therapeutics and Bio-Labs.
November 4, 2020
As part of its commitment to sustainable living and building a healthier Pakistan, Team Bio-Labs organized a Saplings Plantation Event at Gulistan-e-Fatima Park in E-7, Islamabad on October 19, 2020.
September 9, 2020
Proud to have launched RIVONA (Remdesivir) injection for treatment of COVID-19 patients in Pakistan and around the globe. Bio-Labs is a pioneer in introducing the breakthrough treatment not only in Pakistan but globally as well. RIVONA is available for export to international markets as well. For queries, please email: [email protected], [email protected].
June 15, 2020
As a pioneer in Pakistan, Bio-Labs will start production this month of the antiviral drug Remdesivir, which has shown promise in fighting COVID 19 and has recently been approved by US FDA for the respiratory disease caused by the coronavirus.
May 15, 2020
Bio-Labs is proud to have introduced SANITEX to help our nation fight COVID. The hand sanitizer has been made following WHO standards and is available nation wide..
March 25, 2019
New therapeutic products launched including MyVan injection (Vancomycin), Life Tablets (Leflunomide) and P-Trand tablets (Tramadol+Paracetamol)
March 11, 2019
Bio-Labs continues to bring innovative therapeutic solutions in the field of Oncology and Breast Cancer through launch of Letfer Tablets (Letrozole)
February 20, 2019
Pharmacy and Poison Board, Kenya (PPB) successfully culminated audit of Bio-Labs manufacturing facility for re-issuance of Good Manufacturing Practices (GMP) certificate.
January 10, 2019
Proudly launching new products in the field of Skincare/Dermatology. C-Mycin cream (Clindamycin) , Bio Eflorin cream (Eflornithine) , Eslod tablets (Desloratadine) , Flucin cream (Fluocinolone Acetonide), and Flacet N cream (Fluocinolone/Neomycin).
January 15, 2018
Several new and novel lifesaving drugs are launched in the domestic and international markets including TIGABIO Injection ( Tigecycline USP ) and BIOROLAC Ampoule (Ketorolac Tromethamine) and BIOPRIM Injection (Cefepime HCl)
November 30, 2017
Achievement of GMP compliance certificate from FDA Philippines, based on PIC/S Guidelines
August 16, 2017
Drug Regulatory Authority of Pakistan (DRAP) grants approval of veterinary injectable facilities including penicillin liquid, penicillin powder and general liquid injections for veterinary use.
May 20, 2017
Ministry of Public Health & Population, Republic of Yemen successfully conducts a panel inspection of our manufacturing facility and grants GMP/Registration certificate for export of human therapeutic drugs to the Republic of Yemen
January 15, 2017
Bio-Labs establishes a dedicated penicillin facility for manufacturing of oral dosage forms for Animal Health products
October 25, 2016
Bio-Labs received another achievement milestone in form of an award by the Rawalpindi Chamber of Commerce...
March 2, 2016
Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.
December 10, 2015
A new range of dermatology products under the brand name of BUSID CREAM are launched including Fusidic Acid, Betamethasone & Hydrocortisone for better skin infections treatment.
October 12, 2015
Bio-Labs launches BIO-D3, a new range of Vitamin D3 products including dosage forms in liquid ampoules, tablets and drops...
May 12, 2015
Kenya Pharmacy & Poison Board (PPB) grants Good Manufacturing Practices license to Bio-Labs after successful plant inspection allowing further market expansion in the African continent.
June 5, 2014
Bio-Labs recently launched several new products including liquid ampoules such as Iron Sucrose and Vitamin D3 (Cholecalciferol) being manufactured in its new manufacturing facility.
July 15, 2013
Bio-Labs has recently received another accolade of being ranked number 12 in the fastest growing companies in the region known as ARABIA 500 by Harvard University […]
March 10, 2013
Bio-Labs has the honor of being ranked 25th fastest growing company in Pakistan by Harvard Business School Michael Porter’s ALL WORLD NETWORK. For details, please visit: […]
February 15, 2013
Bio-Labs successfully implements SAP business management software technology integrating all core business...
March 5, 2012
New product launch of IROPAS Chewable Tablets and Sugar Free Syrup (Iron Protein Succinylate)
October 2, 2011
Newly developed manufacturing facility for production of sterile liquid ampoules, infusions, and lyophilized injections is approved by MOH, Pakistan
July 14, 2011
Newly renovated manufacturing facility for Cephalosporin Dry Powder Vial Injections commences production
March 10, 2011
Successful registration of several products by international regulatory authorities in Vietnam, Philippines, Saudi Arabia and Afghanistan